<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Trials id="85552"><Title>A multicenter, phase II study of the Hellenic Oncology Research Group (HORG) to assess the safety and efficacy of gemcitabine, cisplatin and docetaxel in patients with muscle-invasive bladder cancer</Title><Indications><Indication>Bladder cancer</Indication></Indications><Phase>Phase 2 Clinical</Phase><Drugs><Drug>gemcitabine</Drug><Drug>docetaxel</Drug></Drugs><RecruitmentStatus>Status not specified</RecruitmentStatus><Sponsor>Hellenic Oncology Research Group</Sponsor></Trials>